UKIZUK Innovation ZonesA TAIU initiative

Compare places

Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.

Side by side

DimensionCambridgeEast of EnglandLiverpool City RegionNorth WestLondonGreater London
Sectors

Life Sciences, Semiconductors, Engineering Biology, Artificial Intelligence

Supporting: Quantum Technologies, Advanced Materials, AgriTech & FoodTech, Digital Technologies

Life Sciences, Engineering Biology, Advanced Materials

Supporting: Digital Technologies, Clean Energy, Creative Industries

Financial Technology, Artificial Intelligence, Creative Industries, Digital Technologies

Supporting: Life Sciences, Quantum Technologies, Engineering Biology, Defence & Security

Research
  • University of Cambridge
  • Wellcome Sanger Institute
  • MRC Laboratory of Molecular Biology
  • University of Liverpool
  • Liverpool School of Tropical Medicine
  • Imperial College London
  • University College London
  • King's College London
  • Queen Mary University of London
  • The Alan Turing Institute
  • The Francis Crick Institute
Companies
  • Cambridge semiconductor and processor IP cluster

Not recorded on the map.

Not recorded on the map.

Infrastructure
  • Babraham Research Campus
  • Cambridge Science Park

University and institute laboratories, genomics and biomedical campus facilities, and semiconductor design capability.

Not recorded on the map.

University research institutes, automated chemistry facilities and port and logistics assets.

  • Digital Catapult
  • Connected Places Catapult
  • Cell and Gene Therapy Catapult
  • Level39

University laboratories, teaching hospitals, data centre and compute capacity, and the densest transport network in the country.

Capital

Specialist deep tech and life science funds, university-linked funds, and corporate partners; strong at seed, thinner at growth stage relative to demand.

A modest local investor base; public and charitable research funding dominate.

  • London venture and growth capital ecosystem

Venture, growth and public market capital at a scale unmatched elsewhere in Europe, plus corporate venture arms and international investors with UK offices.

Government programmes

No place-based designation recorded.

  • Liverpool City Region FreeportFreeports

No place-based designation recorded.

What existsExtreme research density for its size: life sciences and genomics, semiconductor and processor IP, engineering biology and AI, with a mature spin-out culture and specialist investors who understand long timelines.Infection and tropical medicine research of international standing, materials chemistry and automated discovery, a large port and a Freeport designation.Four research-intensive universities, the deepest venture and growth capital pool in Europe, financial regulators, the largest concentration of applied AI companies in the UK and a global-scale creative production economy — all within one travel-to-work area.
What's missing · UKIZ interpretationOwnership retention. Discovery and early company formation work; the Series B onward stage frequently transfers ownership overseas. Laboratory and scale-up space, power and housing also constrain growth.Translation capacity: strong discovery science with limited local scale-up manufacturing and limited early-stage capital to hold companies in the city region.Circulation. Capital, talent and corporate demand concentrate in London rather than flowing outward, so capability elsewhere in Britain competes for attention with opportunities on the investor's doorstep. Cost also pushes production and scale-up activity out without a route back in.
What could connect · UKIZ interpretationCambridge discovery connected to UK manufacturing and biomanufacturing capacity, and to later-stage domestic capital, so that value created here is realised here rather than acquired out of the country.Infection and biologics research connected to North West and Teesside biomanufacturing capacity, with the port used for export rather than only import.London as the demand and capital node of a national network: investors, corporate buyers and regulators deliberately connected to complementary manufacturing, materials and energy capability in the North, Midlands, Scotland and Wales.
UKIZ relevanceCambridge produces intellectual property at a rate few places match, and loses ownership of too much of it at Series B. The proposed Oxford–Cambridge zone concentrates on commercialisation and retention rather than on more discovery.Discovery and manufacture sit unusually close together here. The proposed Manchester mission treats the North West as one health and biomanufacturing geography.London's problem is not capability, it is direction of travel: capital and talent gravitate here rather than circulating. The proposed London zone focuses on using that density to fund and buy from capability elsewhere in Britain.
Last verified15 August 202615 August 202615 August 2026

Proposed by UKIZ · independent · not a government designation